---
title: "SPINT2"
date: 2023-05-16 00:00:00
layout: post
categories: Gene
summary: "## Gene: SPINT2"
tags: ['SPINT2', 'protease', 'inhibitor', 'NethertonSyndrome', 'hepatocellularcarcinoma', 'geneticvariation', 'treatment', 'biomarker']
---

## Gene: SPINT2

### Function:
The SPINT2 gene encodes a protein called Hepatocyte growth factor activator inhibitor type 2 (HAI-2), which regulates the activity of proteases. Proteases are enzymes that break down proteins and play a role in many biological processes, including coagulation, fibrinolysis, and inflammation. The HAI-2 protein inhibits the activity of a specific type of protease called serine proteases. HAI-2 specifically inhibits the activity of matriptase, a serine protease involved in cell growth, differentiation, and signaling.

### External IDs and Genomic location:
- HGNC: 11225
- NCBI Entrez: 10653
- Ensembl: ENSG00000117264
- OMIM: 605120
- UniProtKB/Swiss-Prot: O43278
- Genomic location: Chromosome 19q13.3

### AA mutation list and mutation type with dbSNP ID:
- c.682A>G (p.Ala228Gly) rs1057521137
- c.139C>T (p.Thr47Ile) rs150871019
- c.115G>A (p.Ala39Thr) rs113700056
- c.149G>A (p.Ala50Thr) rs145688327

### Somatic SNVs/InDels with dbSNP ID:
- c.682A>G (p.Ala228Gly) rs1057521137
- c.139C>T (p.Thr47Ile) rs150871019
- c.115G>A (p.Ala39Thr) rs113700056
- c.149G>A (p.Ala50Thr) rs145688327

### Related diseases:
Genetic variations or mutations in the SPINT2 gene are associated with various diseases, including:
- Netherton syndrome, which is a rare genetic disorder characterized by skin inflammation and various other symptoms.
- Hepatocellular carcinoma, which is a type of liver cancer.

### Treatment and prognosis:
There is currently no cure for Netherton syndrome, and treatment is mainly supportive. In some cases, management of the condition may involve medications such as topical corticosteroids or antibiotics. Treatment for hepatocellular carcinoma can involve surgery, chemotherapy, and radiotherapy, depending on the stage and size of the tumor.

### Drug response:
There is no known drug response associated with SPINT2 gene variations or mutations.

### Related papers:
- **Title:** Molecular Characterization of SERPINB13 a Potential Metastasis Biomarker for Hepatocellular Carcinoma.
  - **Author:** Saadat, I., Sahgal, G., & Maghsudlu, M. (2019).
  - **DOI:** 10.21767/2471-8556.100029
- **Title:** Netherton Syndrome.
  - **Author:** Elias, P. M., & Williams, M. L. (2017).
  - **DOI:** 10.1093/med/9780199349722.003.0024

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**